Quick Answer
ELITE PHARMACEUTICALS INC /NV/ reported Cash And Cash Equivalents At Carrying Value of $7.11 million for the year ending 2024.
- ELITE PHARMACEUTICALS INC /NV/ showed a decrease of -9.3% in Cash And Cash Equivalents At Carrying Value from 2023 to 2024.
- This data is from ELITE PHARMACEUTICALS INC /NV/'s annual report (Form 10-K), filed with the SEC on July 1, 2024.
- XBRL data for this metric is available from 2010 to 2024 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2010 to 2024), ELITE PHARMACEUTICALS INC /NV/'s Cash And Cash Equivalents At Carrying Value has grown by 1,129.1%.
- Historical annual values: Fiscal year 2024: $7.11 million | Fiscal year 2023: $7.83 million | Fiscal year 2022: $8.54 million | Fiscal year 2021: $3.19 million | Fiscal year 2020: $1.13 million | Fiscal year 2019: $2.28 million | Fiscal year 2018: $7.18 million | Fiscal year 2017: $10.59 million | Fiscal year 2016: $11.51 million | Fiscal year 2015: $7.46 million | Fiscal year 2014: $6.94 million | Fiscal year 2013: $369.0 thousand | Fiscal year 2012: $668.4 thousand | Fiscal year 2011: $1.83 million | Fiscal year 2010: $578.2 thousand.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: